MERYX INC.

Profile

Company Names

MERYX INC.

Addresses

1414 RALEIGH ROAD, SUITE 445, CHAPEL HILL, NC 27517

130 MASON FARM ROAD, SUITE 3100A, BIOINFORMATICS BUILDING, CHAPEL HILL, NC 27599-7295

102 FLAGSTONE COURT, CHAPEL HILL, NC 27517

Phone Numbers

919-985-7821
919-843-5486

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$7,145,171.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-06-23 
$2,500,000.00 
$2,500,000.00 
$0.00 
Debt 
2
2014-12-18 
$1,544,999.00 
$1,544,999.00 
$0.00 
Equity 
1
2014-04-14 
$3,100,172.00 
$3,100,172.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
H. 
SHELTON 
EARP 
DIRECTOR
MERYX INC.
FRED 
 
ESHELMAN 
DIRECTOR
XORI CORP   |  CORINTHIAN OPHTHALMIC, INC.   |  MERYX INC.   |  NEOANTIGENICS, INC.   |  DIGNIFY THERAPEUTICS, LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  ASEPTICYS, INC.   |  EYENOVIA, INC.   |  ASEPTICYS, LLC
STEPHEN 
V. 
FRYE 
EXECUTIVE OFFICER, DIRECTOR
MERYX INC.
DOUGLAS 
K. 
GRAHAM 
DIRECTOR
MERYX INC.
SAILASH 
 
PATEL 
EXECUTIVE OFFICER
MERYX INC.
SETH 
 
RUDNICK 
DIRECTOR
VAXINNATE CORP   |  LIQUIDIA TECHNOLOGIES INC   |  ENVISIA THERAPEUTICS INC.   |  G1 THERAPEUTICS, INC.   |  LQ3 PHARMACEUTICALS, INC.   |  MERYX INC.   |  ENVISIA THERAPEUTICS, INC.   |  ALTESA BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-06-23 
2014-12-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-18 
2014-04-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-14 
2014-04-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#